The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light
Abstract
BACKGROUND: A medical device is being developed for the reduction of pathogens in PLT concentrates (PCs). The device uses broadband UV light and the compound riboflavin (vitamin B 2). STUDY DESIGN AND METHODS: Pathogens were added to single‐donor PLTs. After treatment, the infectivity of each pathogen was measured using established biologic assays. In vitro PLT performance was evaluated after treatment and after 5 days of storage using a panel of 10 in‐vitro cell quality assays. RESULTS: In studies with viral pathogens, the Pathogen Reduction Technology (PRT) system provided average log reduction factors of 4.46 ± 0.39 for intracellular HIV, 5.93 ± 0.20 for cells associated HIV, and 5.19 ± 0.50 for West Nile virus. For the nonenveloped porcine parvovirus, a reduction factor greater than 5.0 log was observed. Staphylococcus epidermidis and Escherichia coli bacteria were also tested with observed reduction factors to the limits of detection of 4.0 log or greater. PLT cell quality was adequately maintained after treatment and during storage. Although P‐selectin expression, glucose consumption, and lactate production increased relative to controls, this was not beyond accepted levels. The pH of treated PCs also decreased slightly relative to control PLTs on Days 1 and 5. CONCLUSION: The data indicate that the device successfully reduced the number of selected pathogens in PCs. Despite the fact that significant differences exist between treated and control in‐vitro variables, it is speculated that the clinical effectiveness of both products will not be significantly different, based on comparison to historical data for products in routine clinical use today.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lanciotti, R. S., Kerst, A. J., Nasci, R. S., Godsey, M. S., Mitchell, C. J., Savage, H. M., Komar, N., Panella, N. A., Allen, B. C., Volpe, K. E., et al. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.11.4066-4071.2000 · Cited by 1,087 · cited 1×
“The low levels of viremias associated with disease transmissions in these cases are a particular challenge to screening methodologies.(39) Results obtained in this report suggest that PRT treatment is effective in reducing the levels of this virus significantly, thereby rendering disease transmission an extremely low…”
BackgroundManual of Clinical Laboratory Immunology
Balows, A. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00145-4 · Cited by 851
Michelson, A. D., Barnard, M. R., Hechtman, H. B., MacGregor, H., Connolly, R. J., Loscalzo, J., & Valeri, C. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11877 · Cited by 551
Current and Emerging Infectious Risks of Blood Transfusions
Busch, M. P., Kleinman, S. H., & Nemo, G. J. (2003) · JAMA · doi:10.1001/jama.289.8.959 · Cited by 334
Holme, S., Sweeney, J. D., Sawyer, S., & Elfath, M. D. (1997) · Transfusion · doi:10.1046/j.1537-2995.1997.37197176945.x · Cited by 216
Indium‐III: a New Radionuclide Label for Studying Human Platelet Kinetics
Heaton, W. A., Davis, H. H., Welch, M. J., Mathias, C. J., Joist, J. H., Sherman, L. A., & Siegel, B. A. (1979) · British Journal of Haematology · doi:10.1111/j.1365-2141.1979.tb01174.x · Cited by 169
Brecher, M. E., Holland, P. V., Pineda, A. A., et al. (2000) · Transfusion · doi:10.1046/j.1537-2995.2000.40111308.x · Cited by 130
Innis, W. S. A., McCormick, D. B., & Merrill, A. H. (1985) · Biochemical Medicine · doi:10.1016/0006-2944(85)90106-1 · Cited by 60
Cited by
Riboflavin: The Health Benefits of a Forgotten Natural Vitamin
Suwannasom, N., Kao, I., Pruß, A., Georgieva, R., & Bäumler, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030950 · Cited by 444
Emerging infectious disease agents and their potential threat to transfusion safety
Stramer, S. L., Hollinger, F. B., Katz, L. M., Kleinman, S., Metzel, P. S., Gregory, K. R., & Dodd, R. Y. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02279.x · Cited by 427
Riboflavin and health: A review of recent human research
Thakur, K., Tomar, S. K., Singh, A. K., Mandal, S., & Arora, S. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1145104 · Cited by 349
SEGHATCHIAN, J., & KRAILADSIRI, P. (1997) · Transfusion Medicine Reviews · doi:10.1053/tm.1997.0110130 · Cited by 330
Lin, L., Hanson, C. V., Alter, H. J., Jauvin, V., Bernard, K. A., Murthy, K. K., Metzel, P., & Corash, L. (2005) · Transfusion · doi:10.1111/j.0041-1132.2005.04316.x · Cited by 172
“Another system involving riboflavin photochemistry in development for PLT concentrates has not demonstrated this degree of activity.(57) In conclusion, results in this report show that PCT is effective in inactivating viruses from 10 different families, including enveloped, nonenveloped, DNA- or RNAcontaining, provira…”
Result
Metadata
- Authors
- Ruane, P. H., Edrich, R., Gampp, D., Keil, S. D., Leonard, R. L., & Goodrich, R. P.
- Venue
- Transfusion
- Publisher
- Wiley
- Published
- 2004-05-24
- Volume
- 44
- Issue
- 6
- Pages
- 877-885
- ISSN
- 0041-1132 (ISSN-L)
- 1537-2995
- OpenAlex
- W2086847463
- Cited by
- 341
- References
- 8
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.